Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.

Clinical pharmacology and therapeutics - 1 Nov 1996

Chen S, Chou W H, Blouin R A, Mao Z, Humphries L L, Meek Q C, Neill J R, Martin W L, Hays L R, Wedlund P J

Abstract excerpt

OBJECTIVES: This study examined factors that affect cost, reliability, and the value of determining the cytochrome P450 2D6 (CYP2D6) polymorphism in clinical practice. STUDY DESIGN: The method of deoxyribonucleic acid isolation, sample preparation, oligonucleotide primers, and polymerase chain re...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2D6
Share to DNA
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Polymerase Chain Reaction

Share to Polymorphism, Genetic

Share to Reagent Kits, Diagnostic

Share to Reproducibility of Results

Source

Identifiers

PMID: 8941025
DOI: 10.1016/S0009-9236(96)90148-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-8941025-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry.PMID 8941025Read ↗

CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting.Semantic proximity Read ↗

Clinical Utility and Economic Impact of CYP2D6 Genotyping.Semantic proximity Read ↗

Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study.Semantic proximity Read ↗

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.Semantic proximity Read ↗

Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships.Semantic proximity Read ↗

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.Semantic proximity Read ↗

Is pharmacogenetic CYP2D6 testing useful?Semantic proximity Read ↗

Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.Semantic proximity Read ↗

Rapid and reliable method for cytochrome P450 2D6 genotyping.Semantic proximity Read ↗

Cytochrome P450 2D6 polymorphism in eastern Indian population.Semantic proximity Read ↗

Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms.Semantic proximity Read ↗

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.